Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 46

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
6021038
  • C Sequence analysis of the entire coding region

Progressive external ophthalmoplegia with mitochondrial deletions type 3

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SLC25A4 (ANT1) Sequence Analysis

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

C10orf2 (Twinkle) Sequence Analysis

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
21
  • C Sequence analysis of the entire coding region

Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant 3

(AC) Atlanta Center: Medical Neurogenetics, LLC.
United States
11
  • C Sequence analysis of the entire coding region

Mitochondrial Genome Maintenance/Integrity Nuclear Genes NextGen Sequencing (NGS) panel

PreventionGenetics
United States
2722
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

C10orf2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

PEO Panel (MitomeNGS)

Baylor Miraca Genetics Laboratories
United States
188
  • C Sequence analysis of the entire coding region

mtDNA Depletion/Integrity Panel (MitomeNGS)

Baylor Miraca Genetics Laboratories
United States
2215
  • C Sequence analysis of the entire coding region

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories
United States
845637
  • D Deletion/duplication analysis

C10orf2 (TWINKLE) Sequence Analysis (Prenatal Diagnosis)

Baylor Miraca Genetics Laboratories
United States
21
  • T Targeted variant analysis

C10orf2 (TWINKLE) Sequence Analysis

Baylor Miraca Genetics Laboratories
United States
21
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

C10orf2 (TWINKLE) Deletion/Duplication Analysis

Baylor Miraca Genetics Laboratories
United States
21
  • D Deletion/duplication analysis

C10orf2 (TWINKLE) Comprehensive - Sequence & Deletion/Duplication Analysis

Baylor Miraca Genetics Laboratories
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Autosomal Dominant Progressive External Ophthalmoplegia and other C10orf2 -related disorders via the C10orf2 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Spinocerebellar Ataxia

Asper Biotech Asper Biotech Ltd.
Estonia
6663
  • C Sequence analysis of the entire coding region

Progressive external ophthalmoplegia, autosomal dominant, 3

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

Single gene testing C10orf2

CeGaT GmbH
Germany
31
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 46

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.